14-day Premium Trial Subscription Try For FreeTry Free
Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.
Smith & Nephew (SNN) introduces QUADTRAC System and broadens ULTRABUTTON Adjustable Fixation Devices portfolio for ACL reconstruction.

What Makes Smith & Nephew (SNN) a New Buy Stock

01:33pm, Thursday, 23'rd Feb 2023
Smith & Nephew (SNN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Company reports top-line growth in Q4. Innovation & operational leverage finally turning the screw here.
Smith & Nephew plc (NYSE:SNN ) Q4 2022 Earnings Conference Call February 21, 2023 3:30 AM ET Company Participants Deepak Nath - CEO Anne-Francoise Nesmes - CFO Conference Call Participants Jack Reynol
Smith & Nephew PLC (LSE:SN) reported flat annual revenue but declining margins meant operating profit fell sharply. The global medical technology company said operating profit margins slipped to 8.6%

Smith & Nephew Is Reverting to Fair Value

04:04pm, Wednesday, 25'th Jan 2023
The medical device industry has undergone considerable consolidation in recent years, leaving a small number of competitors, and offers long-term growth potential due to increasing longevity, an aging
Smith & Nephew plc (NYSE:SNN ) Q3 2022 Results Conference Call November 3, 2022 4:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Co
Smith & Nephew PLC (LSE:SN) reported a 4.8% increase in underlying revenue for the third quarter and forecast revenue growth for the full year in the middle of its previously guided range of 4%-5%. 
Smith & Nephew PLC (LSE:SN) shares reacted to reports from US medical technology companies that surgical procedure volumes are returning to pre-pandemic levels.
Medical devices manufacturer Smith & Nephew (S&N) has seen its shares sliding. I do not yet see the growth the company is targeting, but business has been recovering and its interim figures were decen

Smith & Nephew: A Medical Equipment Opportunity

04:54pm, Tuesday, 09'th Aug 2022
FTSE 100 constituent and medical equipment maker Smith & Nephew PLC ( SNN , Financial) ( LSE:SN. , Financial) seemed to be making progress after its 2021 results in February.
Smith & Nephew plc (NYSE:SNN ) Q2 2022 Results Conference Call July 28, 2022 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Confe
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE